BIO-X is an early-stage life science commercialization program which uses project calls to select and fund potential services to specific healthcare and society needs. It follows industrial-standard selection and development models to ensure that funding and support goes to projects that possess the potential to meet high scientific, technical and industrial requirements, as well as clearly defined healthcare needs in terms of clinical utility, long-term patient value and cost-efficiency. It receives public funding from the European Regional Development Fund and VINNOVA (the Swedish Governmental Agency for Innovation Systems).